Statement of Purpose and Policy
Metabolic Syndrome and Related Disorders provides an interdisciplinary forum to explore the pathophysiology, recognition, and treatment of the cluster of conditions associated with the evolving entity of metabolic syndrome. These include but are not limited to: central obesity, endothelial dysfunction, insulin resistance, dyslipidemia, glucose intolerance, type 2 diabetes, prothrombotic and pro-inflammatory states, hypertension, cardiovascular disease, and polycystic ovarian syndrome (PCOS). Manuscripts must not contain material that has been reported elsewhere.
The Journal accepts both original contributions and Brief Reviews. Brief Reviews are usually solicited by the Editor or Associate Editors and should be on a relevant topic . Also Brief Reviews should be restricted to approximately 3500 words and 50 references.
Manuscript Submission Fee
Effective May 1, 2013, Metabolic Syndrome and Related Disorders instituted a non-refundable manuscript submission fee of $49.00 USD per submitted paper. This fee is charged regardless of the outcome of editorial decision of acceptance or rejection. In addition to the benefits of publishing your work in Metabolic Syndrome and Related Disorders, your submission provides unique opportunities to increase the visibility of your work through the robust AuthorCite™ services platform, including a link to freely share your article for 30 days. SUBMIT YOUR MANUSCRIPT
Submission fees/codes are NOT required for revisions to papers submitted prior to May 1, 2013. To upload a revision of a paper, the submitting author must log in to their Author Center and click on the “Revised Manuscripts in Draft” link. The paper will appear there, and the submitting author will be able to proceed without paying a submission fee or entering a submission code.
Please be sure to follow the Instructions for Authors below on Manuscript Preparation. Authors whose submissions that do not comply with these Instructions will have their papers returned to them without peer review, and the submission fee will not be refunded. In this circumstance, if you wish to resubmit a returned paper, the standard submission fee of $49.00 USD will be charged again. (This does NOT refer to revisions of peer-reviewed papers.) CLICK HERE TO SUBMIT YOUR MANUSCRIPT
Preparation of Manuscript
Type manuscripts double-spaced. Leave ample margins on sides, top and bottom. Original manuscripts must be no longer than 3,000 words.
The title page should include the authors’ names, academic degrees, and affiliations, the funding source (if appropriate), and a running title of up to 45 characters. Please indicate the name, complete mailing address, phone number, fax number, and e-mail address of the author to whom correspondence should be addressed. The second page should consist of an abstract of no more than 250 words. Abstracts of original articles should contain four paragraphs labeled as: Background, Methods, Results, and Conclusions. Abstracts of reviews should contain a single unstructured paragraph.
Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.” In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.htlm#conflicts for further guidance. If no conflicts exist, the authors must state “No competing financial interests exist."
Tables and Illustrations
Each table with its title must appear on a separate page. Use Arabic numerals to number tables. Each table must stand alone, (i.e., contain all necessary information in the caption), be cited in text, and the table itself must be understood independently of the text. Details of experimental conditions should be included in the table footnotes. Information that appears in the text should not be repeated in the table, and tables should not contain data that can be given in the text in one or two sentences. Tables should be submitted as Microsoft word files, on separate pages from the text of the manuscript. All art should be submitted as TIFF or EPS files. Color, halftones, and grayscale should be at a minimum 300 dpi resolution. Line art should be at a minimum 900 dpi resolution. Color must be saved as CYMK. RGB color files will not work. PowerPoint or Excel files cannot be uploaded. A list of figure legends should be supplied on a separate page at the end of the manuscript, double spaced. We encourage the submission of color figures. Please contact the publisher for color-printing costs.
When naming your figure files, please label them with the first author's last name, followed by a period (.), and then list the figure number. Ex: Smith.0123. Fig1. Label figures and tables inside the files in addition to naming the file with the figure or table number. (ie: When figures or table files are opened, the figure or table number should appear inside the file.)
Please upload individual files of all manuscript material — do NOT upload a single PDF file containing all text, figure, and table files of your paper. Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.
Abbreviations of journal titles should follow MEDLINE.
List references in consecutive numerical order (not alphabetically). All subsequent reference citations should be to the original number. Cite all references in the text or tables using superscript citations. Unpublished data and personal communications should not be listed as references.
References to journal articles should include (1) authors (list first three, then et al.), (2) title, (3) journal name (as abbreviated in MEDLINE), (4) year, (5) volume number, and (6) inclusive page numbers, in that order.
References to books should include: (1) authors, (2) chapter title (if any), (3) editor or author, (4) title of book, (5) city of publication, (6) publisher, and (7) year, in that order. Volume and edition numbers, specific pages, and name of translator should be included when appropriate. The author is responsible for the accuracy and completeness of the references and for their correct text citation.
7. Aljada A, Garg R, Ghanim, H, et al. Nuclear factor-KappaB suppressive and inhibitor-KappaB stimulatory effects of troglitazone in obese patients with type 2 diabetes: evidence of an anti-inflammatory action. J Clin Endocrinol Metab, 2001, 11:224-238.
8. Vinson, G.P, Anderson, D.C, Evidence of Hypertension, Adrenal Glands, Vascular System, and Hypertension, Bristol, UK: Society for Endocrinology; 1997: 1-52.
The author must obtain permission to reproduce figures, tables, and text from previously published material. Written permission must be obtained from the original copyright holder (generally the publisher, not the author or editor) of the journal or book concerned. An appropriate credit line should be included in the figure legend or table footnote, and full publication information should be included in the reference list. Written permission must be obtained from the author of any unpublished material and should accompany the manuscript.
Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.
The Journal is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone: (914) 740–2100; fax: (914) 740–2101.
The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.